Pharming Group is engaged in the development of products for the treatment of unmet medical needs. Pharming Group is engaged in the development of products for the treatment of unmet medical needs.
Pharming Group to participate in September investor conferences PR Newswire LEIDEN, The Netherlands, Aug. 24, 2023 LEIDEN, The Netherlands, Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V...
Pharming Group to convene Extraordinary General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, Aug. 14, 2023 LEIDEN, The Netherlands, Aug. 14, 2023 /PRNewswire/ -- Pharming Group...
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan PR Newswire LEIDEN, The Netherlands, Aug. 9, 2023 Single-arm Phase III study...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales